Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials.
Journal of Clinical Oncology (2011)
- PubMed: 21646604
Available from
Brian Bot's profile on Mendeley.
or
Abstract
Colorectal cancer predominantly occurs in the elderly, but approximately 5% of patients are 50 years old or younger. We sought to determine whether young age is prognostic, or whether it influences efficacy/toxicity of chemotherapy, in patients with advanced disease.
Related
Authors on Mendeley
-
Researcher (at an Academic Institution)Sage Bionetworks
Readership Statistics
17 Readers on Mendeley
by Discipline
65% Medicine
by Academic Status
24% Researcher (at an Academic Institution)
18% Ph.D. Student
18% Student (Postgraduate)
by Country
24% Japan
18% Brazil
12% United Kingdom
Sign up today - FREE
Mendeley saves you time finding and organizing research. Learn more
- All your research in one place
- Add and import papers easily
- Access it anywhere, anytime
